
Immunology


SARS-Cov-2 antibodies detected three months after the infection

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

New protection biomarker against cytomegalovirus in kidney transplant patients

New key element to control interferons during the immune response

“Being able to see the sea everyday from work is wonderful”

Moving forward in immunotherapy research

Dancing to the circadian rhythms

T lymphocyte trajectories in HIV-infected lymph nodes

The microbiome club and the immune system
